Can cannabis reduce opioid requirements for pain?

Observational evidence consistently shows that medical cannabis patients reduce opioid consumption, but RCT evidence is limited. A 2016 systematic review found that 64–79% of medical cannabis patients reported reduced opioid use. A 2019 prospective study of 1,514 patients found a 44% reduction in opioid use after 6 months of medical cannabis. Mechanistically, cannabinoids and opioids act on different but complementary pain pathways — CB1 and opioid receptors are co-expressed in pain-processing regions and show synergistic analgesia in animal models. However, no RCT has directly tested cannabis as an opioid substitute. Pharmacokinetically, CBD inhibits CYP3A4, which metabolizes many opioids, potentially increasing opioid blood levels. The combination requires careful monitoring.